EGFR and lung adenocarcinoma: Although it has been reported that 80% of lung adenocarcinoma with PIK3CA mutations is associated with EGFR mutations [28], no cases with pathogenic co-mutation of PIK3CA and EGFR were detected in our PPC cohort.